Study confirms curable state between single and widespread cancers

by University of Chicago Medical CenterRalph Weichselbaum, M.D., the Daniel K. Ludwig Distinguished Service Professor, chair of radiation and cellular oncology at UChicago and director of the Lud

Updated on: March 01,2024

Study confirms curable state between single and widespread cancers

by University of Chicago Medical CenterRalph Weichselbaum, M.D., the Daniel K. Ludwig Distinguished Service Professor, chair of radiation and cellular oncology at UChicago and director of the Lud

Updated on:March 01,2024

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to

Updated on: July 04,2024

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to

Updated on:July 04,2024

New research discovers new cause of cancer coming from inside us

byFlinders UniversityHusband and wife Professor Simon Conn and Dr Vanessa Conn’s team at the Flinders Centre for Innovation in Cancer has been researching the role of circular RNAs in DNA damage

Updated on: January 12,2024

New research discovers new cause of cancer coming from inside us

byFlinders UniversityHusband and wife Professor Simon Conn and Dr Vanessa Conn’s team at the Flinders Centre for Innovation in Cancer has been researching the role of circular RNAs in DNA damage

Updated on:January 12,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on: February 19,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on:February 19,2024

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,

Updated on: January 03,2024

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,

Updated on:January 03,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on: May 20,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on:May 20,2024

Study confirms pancreatic cancer rates rising faster in women than men

by Cedars-Sinai Medical CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainIn a large-scale nationwide study, investigators from Ceda

Updated on: January 30,2024

Study confirms pancreatic cancer rates rising faster in women than men

by Cedars-Sinai Medical CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainIn a large-scale nationwide study, investigators from Ceda

Updated on:January 30,2024

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on: March 30,2024

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on:March 30,2024

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on: January 04,2024

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on:January 04,2024

Study identifies new therapeutic target for tumor treatment

by Olivia Dimmer,Northwestern UniversityIntratumoral Tregcells have increased mRNA expression ofUsp22andUsp21.(AtoC) mRNA level of YFP+sorted Treg

Updated on: February 03,2024

Study identifies new therapeutic target for tumor treatment

by Olivia Dimmer,Northwestern UniversityIntratumoral Tregcells have increased mRNA expression ofUsp22andUsp21.(AtoC) mRNA level of YFP+sorted Treg

Updated on:February 03,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on: March 05,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on:March 05,2024

Study suggests lung cancer does not decrease in line with reduced smoking

byUmea UniversityIncidence rates for lung cancer according to age, sex and time (cases/100,000 person-years). Notice the different scales on the vertical axes (incidence rates). Credit:Eur

Updated on: April 06,2024

Study suggests lung cancer does not decrease in line with reduced smoking

byUmea UniversityIncidence rates for lung cancer according to age, sex and time (cases/100,000 person-years). Notice the different scales on the vertical axes (incidence rates). Credit:Eur

Updated on:April 06,2024